[1]
“Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment”, Swiss Med Wkly, vol. 135, no. 2324, pp. 352–352, Jun. 2005, doi: 10.4414/smw.2005.11030.